What influences vaccine acceptance: A model of determinants of vaccine hesitancy



Similar documents
Summary of Key Points WHO Position Paper on Vaccines against Human Papillomavirus (HPV) October 2014

Special Considerations

Vaccination: It s what your child would choose. Your guide to childhood vaccinations.

Public Health Ethics. Dr.V.Mohanan Nair. BSc., MBBS, FCGP, MPH, MHSc. (Canada)

Policy Perspective Treatment and Recovery for Individuals and Families Experiencing Addiction January 11, 2016

Models of Health Promotion and Illness Prevention

Scottish Parliament Health and Sport Committee s Inquiry into Teenage Pregnancy in Scotland Evidence from CHILDREN 1 ST

Epidemiology of Vaccine Refusal and Evidence Base for Addressing Vaccine Hesitancy

Ten Good Reasons to Be Concerned about the Human Papillomavirus (HPV) Vaccination Campaign

MINISTRY OF HEALTH PANDEMIC INFLUENZA A / H1N VACCINE FREQUENTLY ASKED QUESTIONS

Influenza Vaccine Frequently Asked Questions. Influenza Control Program

Attitude Fourth Edition

Professional Telesales Skills

Inclusion in the Mainstream. The Challenge for Childcare Providers

Immunisation. Immunisation

MANAGING DIFFICULT BEHAVIOUR

The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011

Coaching and Feedback

UN Human Rights Council UNITED KINGDOM candidate

Black and Minority Ethnic Groups and Alcohol

The timing of vaccination with respect to anaesthesia and surgery. 1. Surgery following immunisation with inactivated vaccines

Dublin Declaration. on Partnership to fight HIV/AIDS in Europe and Central Asia

Three Theories of Individual Behavioral Decision-Making

PATIENTS WANT A HEAVY DOSE OF DIGITAL

Presented by: Deborah Bourne C/O Hope Enterprises Ltd. 25 Burlington Ave., KGN 10, Jamaica W.I

Assessing the State of Vaccine Confidence. In the United States: Recommendations from the. National Vaccine Advisory Committee

Maryland Cancer Plan Pain Management Committee

Policy for delegating authority to foster carers. September 2013

What was the impact for you? For the patient? How did it turn out? How has this helped you in your job? What was the result?

Debbie Robson, RN, MBA, ACHE Executive Director Hospice Care of the West

LAWS AND GUIDELINES REGARDING YOUR INVOLVEMENT IN SHAPING HEALTH POLICY

EQUALITY IMPACT ASSESSMENT

The Role of Patient Advocates and the FDA Deborah J. Miller, Ph.D., M.P.H., R.N. Office of Special Health Issues

Women s Way Direct Mail Project:

Long-Term Care Insurance:

Anthrax vaccine side-effects

Which flu vaccine should you or your child

H1N1 Flu Vaccine Available to All Virginia Beach City Public Schools Students

Top Strategies for Increasing Immunization Coverage Rates

Integrated communication strategy for distribution of H1N1 vaccine

I thank them for their openness, transparency, and willingness to work with WHO to address this newly emerging infection.

User Centric Product Design for Greater End-User Adherence. Primary Data on a 360 o Analysis

CONCEPT NOTE. High-Level Thematic Debate

SUPPORT KNOWLEDGE QUALIFY PETROCTM

Obtaining insurance coverage for human growth hormone treatment for Idiopathic Short Stature In 2003, the Food and Drug Administration (FDA) approved

CODE OF CONDUCT April 2014

Medical Innovation Bill

A Review of the Integration of Brokerage Services in the South West

Operational Definition for Evidence-Based Practices Addictions and Mental Health Division September 11, 2007

Continuous context-specific protection analysis

PRIORITY RESEARCH TOPICS

Pfizer MedEd Grant ID

Immunization Infrastructure: The Role of Section 317

Services for Children and Young People with Special Educational Needs and Disabilities. Lancashire s Local Offer. Lancashire s Health Services

How internal communications saved lives.

South Carolina Perspectives on a Health Insurance Exchange: A Focus Group Research Study

Restorative Parenting: A Group Facilitation Curriculum Activities Dave Mathews, Psy.D., LICSW

Teenage Pregnancy and Sexual Health Marketing Strategy November 2009

Media Contacts: Annick Robinson Investor Contacts: Justin Holko (438) (908)

Learners with Emotional or Behavioral Disorders

Model Policy. Disability Leave. matters

No. 39. An act relating to patient choice and control at end of life. (S.77) It is hereby enacted by the General Assembly of the State of Vermont:

Draft Guidance: Non-economic Regulators: Duty to Have Regard to Growth

GENDER BASED VIOLENCE AT THE WORKPLACE

The link between cervical cancer and HPV (human papillomavirus)

Examples of Quality Improvement Projects in Adult Immunization

Barriers to Effective Pain Management. Dr. Huda Abu-Saad Huijer Director Hariri School of Nursing

Chapter 3: Managing Conflict with Your Boss

Executive Summary. Seven-year research project conducted in three phases

Virtual Mentor American Medical Association Journal of Ethics February 2012, Volume 14, Number 2:

Protecting your child against flu

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Gender Based Violence

CHILDREN S HOSPITAL AND REGIONAL MEDICAL CENTER. Strategic Plan for. Diversity

Participants Manual Video Seven The OSCAR Coaching Model

Health Promotion: Models of Health Promotion

Stewardship of the Code of Medical Ethics

Challenges and Barriers to Community Participation in Policy Development

Principles and standards in Independent Advocacy organisations and groups

Assessing Bullying in New Jersey Secondary Schools

Change Management A 50K Foot View

Communication for Nursing Professionals

APPENDIX I-A: INFORMED CONSENT BB IND Protocol CDC IRB #4167

The guidance 2. Guidance on professional conduct for nursing and midwifery students. Your guide to practice

Child Selection. Overview. Process steps. Objective: A tool for selection of children in World Vision child sponsorship

Pentavalent Vaccine. Guide for Health Workers. with Answers to Frequently Asked Questions

Preparing a Radio Spot Or Poster

The Transpersonal (Spiritual) Journey Towards Leadership Excellence Using 8ICOL

HIV/AIDS POLICY STATEMENT

Understanding Hospice Care. A Guide for Patients and Families

Virtual Mentor American Medical Association Journal of Ethics January 2012, Volume 14, Number 1:

Polio and the Introduction of IPV

How B2B Customer Self-Service Impacts the Customer and Your Bottom Line. zedsuite

Strategic Planning and Support of Distance Learning Programs A Model to Centrally Develop and Locally Support Online and Blended Programs at Tufts

Current Trends in Immunization

Management of Change and Organizational Development. Batch: FO_J11_01 Subject: Management CS Foundation Programme The ICSI Ahmedabad Chapter

Immunization Healthcare Branch. Human Papillomavirus Vaccination Program Questions and Answers. Prepared by

How to Plan and Guide In Class Peer Review Sessions

Vaccine Information Statements

The OIE Regional Communications Workshop. a Strategy for Animal Health Communication. As of 10 November 2009

Transcription:

1 What s vaccine acceptance: A model of determinants of vaccine hesitancy Definition of vaccine hesitancy Vaccine hesitancy is a behavior, d by a number of factors including issues of confidence (do not trust vaccine or provider), complacency (do not perceive a need for a vaccine, do not value the vaccine), and convenience (access). Vaccine hesitant individuals are a heterogeneous group who hold varying degrees of indecision about specific vaccines or in general. Vaccine hesitant individuals may accept all vaccines but remain concerned about vaccines, some may refuse or delay some vaccines, but accept others; some individuals may refuse all vaccines. Definition of confidence Trust in the effectiveness and safety of vaccines and in the system that delivers them, including the reliability and competence of the health services and health professionals and having trust in the motivations of the policy makers who decide which vaccines are needed and when they are needed. Vaccination confidence exists on a continuum, ranging from zero to 100% confidence. Vaccination confidence is only one of a number of factors that affect an individual s decision to accept a vaccine. Definition of vaccine complacency Vaccine complacency exists where perceived risks of vaccine preventable diseases are low and is not deemed a necessary preventive action. Besides perceptions of the threat of disease severity and/or transmission, complacency about a particular vaccine or about in general can be d by under appreciation of the value of vaccine (effectiveness and/or safety profile) or lack of knowledge. Immunization program success may result in complacency and ultimately, hesitancy, as individuals weigh risks of vaccines against risks of diseases that are no longer common as a result of immunization. Definition of convenience The quality of the service (real and/or perceived) and the degree to which services are delivered at a time and place and in a way that is considered appealing, affordable, convenient and comfortable, also affects the decision to vaccinate. Vaccination convenience and complacency are also determined by the priority that an individual places on. Vaccine decision making by a caregiver or patient is a complex process with many factors influencing this both directly and indirectly. Some factors may be more important in certain contexts than in others. Experience and circumstances may change the weight of a factor(s) in different settings.

2 CONTEXTUAL INFLUENCES Influences arising due to historic, sociocultural, al, health system/instit utional, economic or political factors a.communication and media Media and social media can create a negative or positive vaccine sentiment and can provide a platform for lobbies and key opinion leaders to others; social media allows users to freely voice opinions and experiences and it can facilitate the organization of social networks for or against vaccines. b. Influential leaders, gatekeepers and anti or pro lobbies Community leaders and rs, including religious leaders in some settings, celebrities in others, can all have a significant on vaccine acceptance or c.historical s Historic s such as the negative experience of the Trovan trial in Nigeria can undermine public trust and vaccine acceptance, as it did for polio, especially when combined with pressures of influential leaders and media. A community s experience isn t necessarily limited to but may affect it. d.religion/culture/ge nder/socio economic A few examples of the interplay of religious/cultural s include: Some religious leaders prohibit vaccines Some cultures do not want men vaccinating children Some cultures value boys over girls and fathers don t allow children to be vaccinated), e. Politics/policies (Mandates) Vaccine mandates can provoke vaccine hesitancy not necessarily because of safety or other concerns, but due to resistance to the notion of forced f.geographic barriers A population can have general confidence in a vaccine and health service, and be motivated to receive a vaccine but hesitate as the health center is too far away or access is difficult. g.pharmaceutical industry Industry may be distrusted and vaccine hesitancy when perceived as driven only by financial motives and not in public health interest; This can extend to distrust in government when perceived that they are also being pushed by industry and not transparent.

3 INDIVIDUAL and GROUP INFLUENCES Influences arising from personal perception of the vaccine or s of the social/peer a. Experience with past Past negative or positive experience with a particular can hesitancy or willingness to vaccinate. Knowledge of someone who suffered from a VPD due to non may enhance vaccine acceptance. Personal experience or knowledge of someone who experienced an AEFI can also b.beliefs, attitudes about health and prevention Vaccine hesitancy can result from 1) beliefs that vaccine preventable diseases (VPD) are needed to build immunity (and that vaccines destroy important natural immunity) or 2) beliefs that other behaviors (breastfeeding, traditional/alternativ e medicine or naturopathy) are as or more important than to maintain health and prevent VPDs. c.knowledge/awareness Decisions to vaccinate or not are d by a number of the factors addressed here, including level of knowledge and awareness. Vaccine acceptance or hesitancy can be affected by whether an individual or group has accurate knowledge, a lack of awareness due to no information, or misperceptions due to misinformation. Accurate knowledge alone is not enough to ensure vaccine acceptance, and misperceptions may cause hesitancy, but still result in vaccine acceptance. d. Health system and providers trust and personal experience. Trust or distrust in government or authorities in general, can affect trust in vaccines and programmes delivered or mandated by the government. Past experiences that hesitancy can includes system procedures that were too long or complex, or personal interactions were difficult. e. Risk/benefit (perceived, heuristic) Perceptions of risk as well as perceptions of lack of risk can affect vaccine acceptance. Complacency sets in when the perception of disease risk is low and little felt need for. E.g. Patient s or caregiver s perceptions of their own or their children s risk of the natural disease or caregivers perceptions of how serious or life threatening the VPD is. f. Immunisation as a social norm vs. not needed/harmful Vaccine acceptance or hesitancy is d by peer group and social norms

4 VACCINE/ VACCINATION -specific issues Directly related to vaccine or a. Risk/ Benefit (scientific evidence) Scientific evidence of risk/benefit and history of safety issues can prompt individuals to hesitate, even when safety issues have been clarified and/or addressed e.g. suspension of rotavirus vaccine due to intussusception; Guillain Barre syndrome following swine flu vaccine (1976) or narcolepsy (2011) following (A)H1N1 ; milder, local adverse events can also provoke b. Introduction of a new vaccine or new formulation Individuals may hesitate to accept a new vaccine when they feel it has not been used/tested for long enough or feel that the new vaccine is not needed, or do not see the direct impact of the vaccine (e.g. HPV vaccine preventing cervical cancer). Individuals may be more willing (i.e. not complacent) to accept a new vaccine if perception of the VPD risk is high. c. Mode of administrati on Mode of administratio n can vaccine hesitancy for different reasons. E.g. oral or nasal administratio ns are more convenient and may be accepted by those who find injections fearful or they do not have confidence in the health workers skills or devices used. d. Design of program/mode of delivery Delivery mode can affect vaccine hesitancy in multiple ways. Some parents may not have confidence in a vaccinator coming house tohouse; or a campaign approach driven by the government. Alternatively if a health centre is too far or the hours are inconvenient e. Reliability and/or source of vaccine supply Individuals may hesitate if they do not have confidence in the system s ability to provide vaccine(s) or might not have confidence in the source of the supply (e.g. if produced in a country/culture the individual is suspicious of) ; health workers may also be hesitant to administer a vaccine (especially a new one) if they do not have confidence that the supply will continue as it affects their clients trust in them. Caregivers may not have confidence that a needed vaccine and or health staff will be at the health facility if they go there. f. Vaccination schedule Although there may be an appreciation for the importance of preventing individual vaccine preventable diseases, there may be reluctance to comply with the recommended schedule (e.g. multiple vaccines or age of ). Vaccination schedules have some flexibility that may allow for slight adjustment to meet individual needs and preferences. While this may alleviate hesitancy issues, accommodating individual demands are not feasible at a population level. g. Costs An individual may have confidence in a vaccine s safety and the system that delivers it, be motivated to vaccinate, but not be able to afford the vaccine or the costs associated with getting themselves and their child(ren) to the immunization point. Alternatively, the value of the vaccine might be diminished if provided for free. h. Role of healthcare professionals Health care professionals (HCP)are important role models for their patients; if HCPs hesitate for any reason (e.g. due to lack of confidence in a vaccine s safety or need) it can their clients willingness to vaccinate

While some of the factors presented in this matrix could easily be understood as mostly convenience issues (e.g. costs, geographic distance to clinic), to some extent all of these factors can affect confidence (e.g. if I have to pay for the vaccine it can make me hesitate to accept it, because if it was really important, it would be included in the publicly funded program ). Some factors could also be included in the three Cs, depending on the context. For instance, schedule could be understood as a confidence issue (e.g. if parents lack confidence in it too many vaccines, too early ), as a convenience issue (e.g. if parents have transport problems to come for all visits needed to fully immunize their child) or as complacency issue (e.g. if parents don t think that it is important for their child to receive booster doses). Indeed, confidence, complacency and convenience issues can all result in vaccine Understanding how barriers to vaccine uptake belong to one or many of the Cs is important in the design of activities and strategies that could have a positive impact on vaccine The varied drivers of hesitancy require different type of interventions (convenience issues call for activities and strategies such as reducing costs or enhancing geographic access to services, etc. whereas issues around low confidence may require trust building strategies such as improved dialogue). 5